Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

4502

Clasificación en acciones #378
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Precio por acción
$40.26
Capitalización bursátil
$64.06B
Cambio (1 día)
0.71%
Cambio (1 año)
42.44%
País
JP
Comercio Takeda Pharmaceutical Company Limited (4502)

Categoría

Healthcare
EPS de Takeda Pharmaceutical Company Limited (4502)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Takeda Pharmaceutical Company Limited, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Takeda Pharmaceutical Company Limited desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras